Premium
Spontaneous bilateral haemothorax with haemopericardium secondary to rivaroxaban
Author(s) -
Yu JiunHao,
Liu HaoHsuan,
Hsieh MingJer,
Hsieh IChang,
Chu PaoHsien,
Chen DongYi
Publication year - 2020
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/jcpt.13116
Subject(s) - rivaroxaban , medicine , vitamin k antagonist , surgery , thoracentesis , pleural effusion , complication , concomitant , case presentation , thrombosis , anticoagulant , anesthesia , warfarin , atrial fibrillation
What is known and objective Although the risk of major bleeding with non‐vitamin K antagonist oral anticoagulant (NOAC) is low, life‐threatening bleeding can occur. Case summary We report a case of an 81‐year‐old female with deep vein thrombosis who developed bilateral spontaneous haemothorax and haemopericardium after rivaroxaban therapy. Diagnostic thoracentesis revealed a grossly bloody pleural effusion. She was treated with factor eight inhibitor bypassing agent, but the result was not satisfactory. What is new and conclusion To our knowledge, this is the first case report of a concomitant presentation of spontaneous bilateral haemothorax and haemopericardium due to rivaroxaban use. This case highlights the potential risk of major haemorrhagic complication of NOAC, which could be life‐threatening and require emergent reversal.